News | News By Subject | News by Disease News By Date | Search News

Burns News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web

Press Releases
MiMedx Provides Update On Key Clinical Trials     8/31/2016
AcelRx (ACRX) Presents Results From Phase 3 Study Of ARX-04 In The Emergency Department At The International Society For Burn Injuries     8/29/2016
Amarantus BioSciences Announces Publication Of Human Clinical Data For Engineered Skin Substitute In The Treatment Of Life-Threatening Pediatric Severe Burns     8/8/2016
Amarantus Announces cGMP Manufacturing Readiness For Its Engineered Skin Substitute (ESS) Program At Lonza Walkersville     6/8/2016
Cristalia Obtains Registration For First Biotechnological Pharmaceutical Ingredient     6/7/2016
Sanguine Medical Ltd Release: Vivostat Co-Delivery: Cutting-Edge Burn Treatment On Trial     5/9/2016
Avita Medical 's Novel ReNovaCell Technology Offers Key Advantages In Skin Repigmentation Of Burn Scars, When Combined With Medical Needling     5/9/2016
Cytori Therapeutics (CYTX) Reports Preliminary Preclinical Data Supporting Use Of Cytori Cell Therapy For Both The Prevention And Treatment Of Hypertrophic Scars     5/5/2016
Cytori Therapeutics (CYTX) To Present Preliminary Safety And Efficacy Preclinical Data At The 2016 American Burn Association Meeting     4/14/2016
Fibrocell Science, Inc. to Initiate Phase II Clinical Trial for Restrictive Burn Scars     12/17/2012
Derma Sciences, Inc. (DSCI) Announces Issuance of Second U.S. Patent Related to MEDIHONEY Alginate Dressing     6/22/2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP     6/21/2010
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Enters Into Research Agreement With Johns Hopkins Burn Center To Evaluate Ceragenin(TM) Antimicrobial Wound Dressing     5/10/2006
MediWound, Developer Of A Unique Medicament For The Treatment Of Second And Third Degree Burns, Is Entering Phase III Clinical Trials Towards Approval For Marketing In EC     2/13/2006
BioSpecifics Technologies Corporation (BSTC) Announces Abbott Laboratories (ABT) To Market Collagenase Santyl(R) Ointment     11/4/2003